Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transscleral ruby laser cyclocoagulation.

H Beckman, J Waeltermann

    American Journal of Ophthalmology
    |December 15, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Transscleral ruby laser cyclocoagulation effectively lowered intraocular pressure in 62% of glaucoma patients. This treatment showed better visual results and less discomfort compared to cyclocryotherapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The examination of toxaphene by gas chromatography.

    Bulletin of environmental contamination and toxicology·2013
    Same author

    Separation and detection of submicrogram quantities of pesticides by an improved TLC technique.

    Bulletin of environmental contamination and toxicology·2013
    Same author

    The characteristics and operation parameters of a thermionic emission detector, selective and sensitive to phosphorus.

    Bulletin of environmental contamination and toxicology·2013
    Same author

    A method for the determination of pentachlorophenol in human urine in picogram quantities.

    Bulletin of environmental contamination and toxicology·2013
    Same author

    A method for the determination of toxaphene in the presence of DDT.

    Bulletin of environmental contamination and toxicology·2013
    Same author

    Blood transfusion malaria in the post war period.

    The interne·2010
    Same journal

    Forging Ahead: The Need for Improved Representation in Academic Ophthalmology.

    American journal of ophthalmology·2026
    Same journal

    Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI.

    American journal of ophthalmology·2026
    Same journal

    Therapeutic Advances in Corneal Scar management: Topical Treatments, Mesenchymal Cell Therapy and Stromal Transplantation.

    American journal of ophthalmology·2026
    Same journal

    Increased Risk for Ocular Surface Neoplasia in Recipients of Solid Organ Transplant.

    American journal of ophthalmology·2026
    Same journal

    Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: Optical Coherence Tomography Angiographic changes from a randomized clinical trial.

    American journal of ophthalmology·2026
    Same journal

    Posterior Segment Risk Factors for Penetrating Keratoplasty Failure.

    American journal of ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Glaucoma Management
    • Surgical Interventions

    Background:

    • Glaucoma is a leading cause of irreversible blindness.
    • Effective intraocular pressure (IOP) control is crucial for preventing glaucomatous optic neuropathy.
    • Transscleral laser cyclocoagulation offers a therapeutic option for refractory glaucoma.

    Purpose of the Study:

    • To evaluate the efficacy and safety of transscleral ruby laser cyclocoagulation for IOP reduction.
    • To assess treatment success rates across different glaucoma subtypes.
    • To compare outcomes with alternative cyclodestructive procedures.

    Main Methods:

    • A retrospective analysis of 241 eyes treated with transscleral ruby laser cyclocoagulation over a ten-year period.
    • Minimum follow-up of six months (average 24 months).

    Related Experiment Videos

  • Success defined as IOP between 5 and 22 mm Hg.

    • Main Results:

    • Overall success rate of 62% (150/241 eyes).
    • Highest success in aphakic open-angle glaucoma (86%), lowest in neovascular glaucoma (53%).
    • Most eyes maintained preoperative visual function; chronic hypotony and phthisis were noted complications.

    Conclusions:

    • Transscleral ruby laser cyclocoagulation is an effective treatment for lowering IOP in various glaucoma types.
    • The procedure offers favorable visual outcomes and reduced complications compared to cyclocryotherapy.
    • Careful patient selection is important, especially in neovascular glaucoma, due to potential complications.